13例涎腺腺癌的临床分析

Clinical Analysis for Therapy and Prognosis of Adenocarcinoma Salivary Glands:A Report of 13 Cases

  • 摘要: 目的 :了解涎腺腺癌发病情况、构成特点,并探讨13例涎腺腺癌的治疗方式和治疗效果,指导临床实践。 方法 :按照WHO涎腺肿瘤组织学分类标准,对13例经病理确诊的涎腺腺癌部位分布、发病年龄、性别进行回顾性分析,并对其术后生存情况进行长期跟踪随访。 结果 :腮腺是最主要发病部位。男性患者(61.5%)稍多于女性(38.5%)。涎腺腺癌患者平均发病年龄49.6岁,13例涎腺腺癌患者中位生存时间为8.5年,3年生存率为83.3%,5年生存率为66.7%。 结论 :涎腺腺癌发病男性占优势,以腮腺最好发,手术治疗为主,首次手术彻底为治疗关键,治疗计划需个性化,患者死亡主要发生于术后6年之内,过后生存时间显著延长。

     

    Abstract: Objective :To investigate the clinical features, the operative type and therapeutic-effi-cacy of adenocarcinoma salivary glands. Methods : Thirteen cases of salivary glands adenocarcinomawere reviewed and pathologic diagnosis was based on the WHO Classification. The clinical featureswere retrospectively analyzed and followed-up for prognosis. Results : Parotid gland was the most com-mon location of salivary adenocarcinoma. In the 13 cases, the average age of onset was 49.6, with amale preponderance. The median survival time, 3-year and 5-year survival rate was 8.5years, 83.3%,and 66.7%, respectively. Conclusions :The male patients predominate in the incidence of adenocarci-noma salivary glands, with parotid as the predilection site, surgical operation as the main treatment,complete initial-operation as the key of the treatment.Individualization is needed in the regimens. Themortality occurs mainly within 6 years after operation, after which the survival time significantly pro-longs.

     

/

返回文章
返回